AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
AssigneeWayne State University
InventorZhuo-Hua Pan
Life of this patent
Estimating the term…
Loading patent…
AssigneeWayne State University
InventorZhuo-Hua Pan
Estimating the term…
Microbial type rhodopsins, such as the light-gated cation-selective membrane channel, channelrhodopsin-2 (Chop2/ChR2) or the ion pump halorhodopsin (HaloR) are expressed in retinal ganglion cells upon transduction using recombinant AAV vectors. Selective targeting of these transgenes for expression in discrete subcellular regions or sites is achieved by including a sorting motif in the vector that can target either the central area or surround (off-center) area of these cells. Nucleic acid molecules comprising nucleotide sequences encoding such rhodopsins and sorting motifs and their use in methods of differential expression of the transgene are disclosed. These compositions and methods provide significant improvements for restoring visual perception and various aspects of vision, particular in patients with retinal disease.
A polynucleotide molecule comprising a nucleic acid sequence encoding a rhodopsin for expression in subcellular regions of a retinal neuron, comprising:
A recombinant adeno-associated virus-2 (rAAV2) expression vector comprising a nucleic acid molecule encoding a rhodopsin for expression in subcellular regions of a retinal neuron comprising:
A recombinant adeno-associated virus-2 (rAAV2) expression vector comprising a schematic structure selected from:
Dependencies are inferred from the claim text.